Accuvest Global Advisors Moderna, Inc. Transaction History

Accuvest Global Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $34,009 - $46,072	287 Added 16.87%	1,988 $241,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $230,757 - $335,131	-1,701 Reduced 50.0%	1,701 $261,000
Q4 2022 Jan 12, 2023	BUY	$118.38 - $210.04 $153,775 - $272,841	1,299 Added 61.77%	3,402 $0
Q3 2022 Oct 20, 2022	SELL	$118.07 - $194.18 $80,641 - $132,624	-683 Reduced 24.52%	2,103 $249,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $10,424 - $15,716	-89 Reduced 3.1%	2,786 $398,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $181,849 - $338,001	1,438 Added 100.07%	2,875 $495,000
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $324,503 - $529,548	1,437 New	1,437 $365,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

Stay updated on Accuvest Global Advisors with notifications on news.